reason report weekli
 medic devic index outperform broad market
index increas week versu
gain howev medic devic hospit
suppli continu modestli under-perform
versu year-to-d loss
week ahead week calendar earn season
continu o/v rate report oper result
market close wednesday march addit host
ndr rate day contact stephen
repres inform week o/v rate esta
report oper result market open monday
march host rate ndr
announc compani voluntarili paus omnipod horizon
pivot studi order correct softwar issu paus due
error select case relat cgm signal process
incorrect could impact insulin deliveri importantli injuri
advers event report time compani
expect resum trial end april howev due
paus pivot trial compani expect commerci
earli rather prior goal commerci
paus temporari share like pressur
given compani rel high multipl market weak
tuesday march highlight posit insid activ o/v
rate specif compani chief execut offic mr
burn acquir share common stock exercis
stock option date given recent weak
share rel discount valuat remain encourag
transact note insider/stakehold ownership stand
publish februari edit catheter
cardiovascular intervent highlight data nation
inpati sampl ni databas demonstr non-
emerg high-risk patient underw pci
impella lower rate mortal complic iabp
patient specif impella cohort demonstr follow
result compar iabp cohort lower in-hospit mortal
import disclosur analyst certif page report report constitut compendium report cover six
subject compani stephen inc choos provid specif disclosur compani mention refer
access current disclosur compani report client refer
contact stephen inc repres addit inform
lower respiratori complic vs similar rate bleed vs furthermor
impella cohort significantli sicker iabp cohort
also wednesday e/v rate announc compani sign definit agreement acquir exocad global
hold gmbh privat million cash transact expect close oper period
exocad global compani cad/ cam softwar market offer fulli integr workflow dental lab
practic detail term acquisit yet releas expect acquisit accret
gross margin dilut ep non- basi acquisit accret gross
oper margin neutral earn addit exocad profit busi grow
importantli invest serv improv visual offer strengthen compani posit
restor marketplac drive align volum
thursday march rate report oper result led us reiter rate increas
former price target per share compani fiscal oper result reflect
number move piec clearli invest year remain pois realiz durabl high- mid-
single-digit organ revenu growth realiz oper leverag accordingli remain continu
see opportun acceler organ revenu growth myday capac increas misight rolled-out
ecp increasingli fit astigmat patient toric new fertil contract commenc addit csi
gross oper margin stand improv rel fiscal level dtc spend normal manufactur
varianc absorb result modest earn leverag signific increas
friday march publish note o/v rate follow attend intern seat
symposium iss enhanc confid ivc abil sustain acceler compani core
power mobil busi specif busi stand benefit entri front-wheel drive system
market stander fulli compli group bill industri first pediatr stander
well three new product tent launch prior cye result view ivc power
mobil portfolio associ new product line-up favor enter season stronger calendar year
remain optimist either meet exceed conserv growth estim power
mobil busi segment estim compris total revenu
fda clear compani basal-iq technolog interoper autom glycem control iagc recal
also receiv iagc design compani slim insulin pump control-iq importantli
pump basal-iq technolog util o/v rate sensor predict prevent low specif
technolog predict glucos level minut ahead time order prevent low-glucos event suspend insulin
valu expect drop mg/dl cgm read fall mg/dl
note dollar million except per share data ep alc
elgx fulli tax pro forma
rate stephen inc overweight equal-weight underweight volatil susp suspend
percentag chang price
insulet corporati
surgi cal inc
edward li fescienc corporati
compani document stephen inc estim rate
stephen inc otherwis estim base upon consensu
page
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
